Mucosal Melanoma
📧 Sign up to get email alerts when something new happens for Mucosal Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: Using Nivolumab Alone or With Cabozantinib to Prevent Mucosal Melanoma Return After Surgery [Phase 2]
A Phase 2 clinical trial evaluating nivolumab alone or in combination with cabozantinib to prevent recurrence of mucosal melanoma after surg…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: Neoadjuvant SHR-1701 Plus Famitinib With Response-guided Adjuvant Therapy in Resectable Mucosal Melanoma [Phase 2]
Clinical trial update on using SHR-1701 plus famitinib as neoadjuvant therapy with response-guided adjuvant treatment for resectable mucosal…
-
CLINICAL_TRIALS research · 2026-04-02Clinical Trial Update: Intravenous and Intrathecal Nivolumab in Treating Patients With Leptomeningeal Disease [Phase 1]
Phase 1 study evaluating intravenous and intrathecal nivolumab for leptomeningeal disease in melanoma and non-small cell lung cancer patient…
-
CLINICAL_TRIALS research · 2026-04-01Clinical Trial Update: Studying Off Label Insurance Coverage for Patients With Cutaneous Cancers a "Filter" Observational Study
An observational study examining off-label insurance coverage for patients with select cutaneous cancers, sponsored by Ohio State University…
-
CLINICAL_TRIALS research · 2026-03-16Clinical Trial Update: A Phase 1-1b Study to Evaluate the Safety, Efficacy and Dosimetry of Study Drug A9-3408 in Subjects With Metastatic Melanoma [Phase 1]
A Phase 1-1b clinical trial is evaluating the safety, preliminary efficacy, and dosimetry of study drug A9-3408 in patients with metastatic …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-02-19Clinical Trial Update: Neo IRENIE (NEOadjuvant Ipilimumab, RElatlimab, NIvolumab Evaluation) [Phase 2]
A Phase 2 neoadjuvant trial (Neo IRENIE) evaluating a triple combination of ipilimumab, relatlimab, and nivolumab in resectable cutaneous an…
-
CLINICAL_TRIALS research · 2026-02-18Clinical Trial Update: Axitinib and Nivolumab for the Treatment of Mucosal Melanoma [Phase 2]
A Phase 2 trial evaluating the combination of axitinib and nivolumab for mucosal melanoma is currently recruiting.
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: Neo-adjuvant Immunotherapy in Patients With Localized Melanoma [Phase 2]
Phase 2 clinical trial update on neo-adjuvant immunotherapy for localized melanoma, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Iparomlimab and Tuvoraleimab Injection in Combination With Bevacizumab, Albumin-bound Paclitaxel, and Carboplatin as First- or Second-line Treatment for Patients With Advanced Acral and Mucosal Melanoma [Phase 2]
Phase 2 clinical trial evaluating a combination including iparomlimab and tuvoraleimab with bevacizumab, nab-paclitaxel, and carboplatin as …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Paclitaxel Polymersomes + Carboplatin + Adebelimab: Neoadjuvant Phase Ⅱ Single-Arm Study for Resectable Mucosal Melanoma [Phase 2]
A Phase 2 single-arm neoadjuvant trial evaluating Paclitaxel Polymersomes with Carboplatin and Adebelimab in patients with resectable mucosa…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Oral Decitabine/Cedazuridine (DEC-C) in Combination With Nivolumab for Patients With Mucosal Melanoma [Phase 1, Phase 2]
Clinical trial update describes a Phase 1/2 study of oral decitabine/cedazuridine (DEC-C) in combination with nivolumab for patients with mu…
-
CLINICAL_TRIALS research · 2025-12-03Clinical Trial Update: Clear Me: Interception Trial to Detect and Clear Molecular Residual Disease in Patients With High-risk Melanoma [Phase 2]
A Phase 2 trial named Clear Me aims to detect and clear molecular residual disease in high-risk melanoma and is currently recruiting, includ…
-
CLINICAL_TRIALS research · 2025-11-19Clinical Trial Update: Combination of Carilizumab, Apatinib, and Radiotherapy for Advanced Mucosal Melanoma [Phase 2]
A Phase 2 clinical trial is evaluating the combination of Carilizumab, Apatinib, and radiotherapy for advanced mucosal melanoma, which is cu…
-
CLINICAL_TRIALS research · 2025-11-12Clinical Trial Update: Time-of-Day Specified Immunotherapy for Advanced Melanoma, The TIME Trial [Phase 2]
Phase 2 trial evaluating time-of-day specified immunotherapy for advanced melanoma; currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-11Clinical Trial Update: A Study to Compare the Administration of Encorafenib + Binimetinib + Nivolumab Versus Ipilimumab + Nivolumab in BRAF-V600 Mutant Melanoma With Brain Metastases [Phase 2]
Phase 2 study compares encorafenib + binimetinib + nivolumab versus ipilimumab + nivolumab in BRAF-V600 mutation melanoma with brain metasta…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors [Phase 1, Phase 2]
Phase 1/2 study of APG-115 alone or with pembrolizumab in metastatic melanoma and other advanced solid tumors; the trial is currently active…
-
CLINICAL_TRIALS research · 2025-04-04Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy [Phase 2]
Phase 2 study evaluating IBI363 monotherapy versus pembrolizumab for unresectable locally advanced or metastatic mucosal or acral melanoma i…
-
CLINICAL_TRIALS research · 2024-08-21Clinical Trial Update: Carbon Ion Radiation Therapy in the Treatment of Mucous Melanomas of the Female Lower Genital Tract [NA]
A clinical trial update indicates recruitment for a carbon ion radiotherapy study targeting mucosal melanoma of the female lower genital tra…
-
CLINICAL_TRIALS research · 2024-05-22Clinical Trial Update: A Trial of AK104 or AK112 in Combination With Axitinib in Patients With Metastatic Mucosal Melanoma [Phase 1]
A Phase 1 clinical trial update describing AK104 or AK112 in combination with Axitinib for metastatic mucosal melanoma, currently not yet re…